Simona Halep from Romania is planning a surgical breast reduction in order to improve her performance. Do the fans agree that this is a good idea? Find out on Fanarchy, Tuesdays at 10:30ET on VERSUS.
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
Major companies are helping to find a cure through donations, selling inspirational pink products and creating revolutionary breast scanning technology. Here are a few ways you can help.
It's no surprise that about 1 in 8 women in the United States will develop invasive breast cancer over the course of her lifetime. In fact, for women in the U.S., breast cancer death rates are higher than those for any other cancer, besides lung cancer. In honor of Breast Cancer Awareness Month in October, our national healthcare expert is here to discuss educating and empowering women to take charge of their own breast health.
Nearly five black women die needlessly per day from breast cancer in the United States – a total of 1,722 deaths annually – according to a study released today at the Avon Foundation Breast Cancer Forum and simultaneously published in Cancer Epidemiology. The 2012 Racial Disparity in Breast Cancer Mortality Study found that 21 of the 25* largest U.S. cities have a black: white disparity in breast cancer mortality, 13 of which are statistically significant.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52895-avon-foundation-breast-cancer-forum-racial-disparity-mortality-study
Phenogen Sciences, Inc. [www.phenogensciences.com] today announced the immediate availability of BREVAGen™, a predictive risk test for the millions of women at above average risk of developing estrogen-receptor positive breast cancer. This first-in-class, scientifically-validated risk assessment test examines a woman’s clinical risk factors, such as her lifetime exposure to estrogen, combined with scientifically validated genetic markers to determine each patient’s personalized five-year and lifetime risk of developing breast cancer.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58399-phenogen-sciences-brevagen-breast-cancer-risk-assessment-test-availability
Lynn Napoli Marynowski and her younger brother Frank Napoli are as close as a big sister and little brother can be. They are an extension of their tight-knit family. From being raised together (along with a brother), to working together—Lynn has worked at the Chicago Mercantile Exchange for 25 years and Frank 17 years—and, to this day, still living nearby each other, their parents and brother in Chicago and surrounding suburbs, Lynn and Frank share a close sibling connection. So, when Lynn was struck with the diagnosis of Stage 3 breast cancer back in June 2012, that road—no matter how long—would also be theirs to travel together.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63625-northwestern-memorial-hospital-lynn-sage-cancer-research-foundation
Avon Products, Inc. celebrated the culmination of its 125th anniversary year last night at the Avon Foundation for Women Global Voices for Change Gala by honoring global champions working to end breast cancer and domestic violence, and by announcing the winners of Avon’s first-ever global online singing talent search for women and songwriting competition for women and men, Avon Voices. Avon Chairman and CEO Andrea Jung, Fergie, Natasha Bedingfield, Delta Goodrem, Ashley Greene and more than 800 guests and performers from 39 countries attended this star-studded celebration at the Marriot Marquis in New York City’s Times Square, which raised more than $2.3 million for the Avon Foundation for Women.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46211-avon-global-voices-for-change-gala
The 10th annual Avon Foundation for Women Gala tonight honored exceptional women and men for their efforts to end breast cancer and violence against women. The event, held at Cipriani 42nd Street in New York City, has raised more than $20 million for Avon philanthropy in the decade since it launched. The event was hosted by Reese Witherspoon, award-winning actress and Honorary Chair of the Avon Foundation for Women, and Andrea Jung, Chairman and CEO, Avon Products, Inc., with a special musical performance by Melissa Etheridge.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/avon/42979/
